# Cancer Genetics, Epigenetics, and Genomics Program

> **NIH NIH P30** · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · 2020 · $6,764

## Abstract

CANCER GENETICS, EPIGENETICS & GENOMICS RESEARCH PROGRAM 
ABSTRACT 
The Cancer Genetics, Epigenetics, and Genomics Research Program (CGEG) is a trans-disciplinary program 
that uses genetic, biochemical and genomic approaches to understand cancer susceptibility, etiology, and 
progression; identifies diagnostic and prognostic biomarkers and therapeutic targets; and works to translate 
these discoveries to clinical and community interventions. The research of the CGEG Program encompasses 
three specific aims centered on the characterization of unique patterns of gene expression in normal and 
cancer cells; the definition of the pathways that regulate genome stability and their response to environmental 
carcinogens in normal and cancer cells; and the identification of mutational and gene expression signatures in 
leukemia, lung cancer, and other cancers with increased incidence and/or mortality in New Mexico populations 
that can be translated to clinical and community interventions.The Program is co-led by Steven Belinsky, PhD, 
an expert in the application of translational epigenomics to lung cancer etiology, and Mary Ann Osley, PhD, an 
expert in the definition of basic epigenetic mechanisms in genome regulation. The program is comprised of 27 
members (22 full and 5 associate) from 14 Departments/Schools/Consortium Partners whose work is 
supported by $6,736,043 in annual direct cost funding, of which $2,005,422 is from the NCI and $6,252,544 is 
peer-reviewed as of 9/1/2014. The discoveries made in this program have resulted in 226 publications, of 
which 32% are intra-programmatic collaborations and 31% are inter-programmatic collaborations, with a total 
collaborative publication level of 52%.

## Key facts

- **NIH application ID:** 10230664
- **Project number:** 3P30CA118100-15S9
- **Recipient organization:** UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
- **Principal Investigator:** CHERYL LYNN WILLMAN
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $6,764
- **Award type:** 3
- **Project period:** 2005-09-26 → 2021-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10230664

## Citation

> US National Institutes of Health, RePORTER application 10230664, Cancer Genetics, Epigenetics, and Genomics Program (3P30CA118100-15S9). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10230664. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*